Market Size of South Korea Neurology Devices Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 6.80 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
South Korea Neurology Devices Market Analysis
The South Korea Neurology Devices Market is expected to grow with a CAGR of 6.8% during the forecasted period.
COVID-19 had a significant impact on the growth of the market in South Korea. This was mainly due to the reduction of neurological services during the initial stages of the pandemic owing to the imposition of strict lockdown procedures. For instance, the NCBI article published in May 2022 mentioned that the causes of the disruption of neurological services in south korea were due to the closure of inpatient or outpatient services or consultations as per health authority directives and decreased volume of patients due to the cancellation of elective care. Such disruption of neurological services in South Korea due to the pandemic had a significant impact on the growth of the market during the pandemic period. However, the resumption of neurology services in this country after the relaxation of strict lockdown regulation during the post-pandemic period is expected to boost the growth of the market over the forecast period.
The key factors propelling the growth of this market are an increase in the incidence of neurological disorders, huge investments by private players in neurology devices, and an increase in R&D in the field of neuro therapies.
The population in South Korea is aging rapidly. According to the World Population Ageing 2021 report, in South Korea population aged above 65 years or over is expected to reach 12.658 million (24.7%) by 2030. This growing geriatric population is more prone to neurological disorders such as Alzheimer's disease, and Parkinson's' disease which is expected to drive the growth of the market over the forecast period. Also, the increasing incidence of neurological disorders is one of the factors propelling the market growth. For instance, an NCBI article published in May 2022, reported that in South Korea, the age-standardized incidence of Alzheimer's during this timeframe has increased from 1.83 per 1,000 persons in 2020 to 5.21 per 1,000 in 2021. The age-standardized prevalence of Alzheimer's disease increased from 3.17 to 15.75 per 1,000 persons.
Thus, owing to the above factors the market is expected to show significant growth over the forecast period.
